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Chlamydia trachomatis causes a high number of sexu-
ally transmitted infections worldwide, but reproducible and 
precise strain typing to link partners is lacking. We evalu-
ated multilocus sequence typing (MLST) for this purpose 
by detecting sequence types (STs) concordant for the 
ompA genotype, a single-locus typing standard. We tested 
samples collected during April 2000–October 2003 from 
members of established heterosexual partnerships (dyads) 
in the Indianapolis, Indiana, USA, area who self-reported 
being coital partners within the previous 30 days. C. tracho-
matis DNA from 28 dyads was tested by MLST; sequences 
were aligned and analyzed for ST and phylogenetic rela-
tionships. MLST detected 9 C. trachomatis STs, 4 unique to 
Indianapolis; STs were identical within each dyad. Thirteen 
unique strains were identified; 9 (32%) dyads harbored nov-
el recombinant strains that phylogenetically clustered with 
strains comprising the recombinants. The high rate of novel 
C. trachomatis recombinants identified supports the use of 
MLST for transmission and strain diversity studies among 
at-risk populations.
Chlamydia trachomatis, a bacterium that can infect both men and women, is most commonly sexually trans-
mitted. In 2008, approximately 105.7 million new C. tra-
chomatis sexually transmitted infections (STIs) occurred 
worldwide (1); an estimated 2.86 million incident cases oc-
curred in the United States (2). The last surveillance study 
of STIs in the United States, in 2011, reported 1,412,791 
chlamydial infections, the largest case number for any 
disease ever reported to the Centers for Disease Control 
and Prevention (3). 
C. trachomatis infections in men and women are most-
ly asymptomatic; thus, continued sexual activity among 
persons unaware of their infection status facilitates further 
transmission. Gaps in knowledge of chlamydial STIs in-
clude how measures of immunity, bacterial load, condom 
use, and other factors relate to transmission risk. Longitu-
dinal studies of these factors are needed to inform treatment 
and prevention strategies (4). The tools required include 
careful ascertainment of sexual history and behavioral de-
terminants and reproducible and discriminating biomarkers 
to strengthen the case for transmission between sex part-
ners linked by partner tracing.
The standard biomarker for these studies is ompA ge-
notyping, but this method lacks precision because the gene 
is under immune selection and represents only 0.1% of the 
genome. Because large-scale whole-genome sequencing 
of clinical samples is not yet feasible, multilocus sequence 
typing (MLST) for C. trachomatis has been developed 
to provide greater insight into strain types; 3 such MLST 
methods have been reported in the literature (5–10). The 
scheme we developed, on the basis of analysis of 19 ref-
erence strains and 68 geographically diverse clinical iso-
lates, identified 44 MLST sequence types (STs), compared 
with only 20 ompA genotypes (11). In our scheme, we were 
also able to discriminate single-nucleotide polymorphisms 
(SNPs) that correlate with disease phenotypes attributable 
to C. trachomatis: lymphogranuloma venereum (LGV), tra-
choma, and non-LGV urogenital diseases (11). Our scheme 
has since been expanded to encompass 192 geographically 
and clinically diverse samples.
For this study, we applied our MLST scheme to a 
subset of a well-defined heterosexual partnership (dyad) 
cohort in Indianapolis, Indiana, USA, comprising 28 dy-
ads for which concordance of the ompA genotype existed 
between partners. The purpose of the study was to deter-
mine whether MLST, which provides a more detailed level 
of strain typing than ompA genotyping, would also show 
strain concordance between partners, as would be expected 
if transmission had occurred within the dyads. In addition, 
we sought to identify additional C. trachomatis strain types, 
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beyond those identified by ompA genotyping, that might be 
unique to Indianapolis, because this geographic region has 
not previously been included in any MLST database.
Materials and Methods
Study Population
A study of C. trachomatis concordance in heterosexual 
partnerships (dyads) was conducted in Indianapolis during 
April 2000–October 2003; participants were sexually ac-
tive heterosexual men and women 15–25 years of age who 
visited an urban STI clinic (12). Written informed consent 
was obtained, and the study was approved by the Indiana 
University–Purdue University Institutional Review Board. 
Eligibility was defined as self-reported sexual activity be-
tween the partners during the previous 30 days. A total of 
210 heterosexual dyads were established by research dis-
ease intervention specialists and enrolled. C. trachomatis 
infection was identified by Amplicor CT/NG (Roche Di-
agnostics, Indianapolis, IN, USA) nucleic acid amplifica-
tion test and cell culture, as previously described (12). Of 
the 210 dyads, 130 contained >1 C. trachomatis–infected 
partner; for 45 dyads, both partners were infected and had 
identical ompA genotypes. 
For the MLST study, we used remainder samples 
from 56 members of 28 dyads who were concordant for 
C. trachomatis infection and ompA genotype. These sam-
ples were provided to investigators at Children’s Hospital 
Oakland Research Institute (CHORI) in a de-identified and 
blinded fashion. Thus, CHORI research was considered 
not to involve human subjects, and informed consent was 
not required.
Reference and Clinical Samples
We used 56 samples (from cervix in women and urethra 
in men) from 28 dyads in which persons within each dyad 
were concordant for C. trachomatis infection and ompA 
genotype. Additionally, we used for analysis MLST data 
for 20 C. trachomatis reference strains (A/Sa1, A/HAR13, 
B/TW5/OT, Ba/Apache2, C/TW3/OT, D/UW3/Cx, Da/
TW448, E/Bour, F/ICCal3, G/UW57/Cx, H/UW4/Cx, I/
UW12/Ur, Ia/UW202, J/UW36/Cx, Ja/UW92, K/UW36/
Cx, L1/440, L2/434, L2a/UW396, L3/404) and 172 clinical 
samples in the MLST database (http://www.mlst.net).
ompA Genotyping and MLST Analyses
ompA genotyping of the samples had been previously 
performed at Indiana University (13,14) as part of the ear-
lier C. trachomatis concordance study. Cultured and non-
cultured clinical samples were sent to CHORI for analysis 
(11). DNA was extracted, and MLST for 7 housekeep-
ing genes was performed by using primers as described 
(11; http://www.mlst.net; online Technical Appendix 
Table 1, http://wwwnc.cdc.gov/EID/article/20/11/14-0604- 
Techapp1.pdf). A consensus sequence was created from 
forward and reverse sequences, and the genes were con-
catenated and queried against all 202 MLST sequences in 
the database (15). Sequence output was used to identify 
each unique allelic profile to assign an ST, and all STs were 
deposited in the C. trachomatis database (http://chlamydia.
mlst.net). The concatenated sequences of the 7 MLST loci 
and the allelic profiles for each sample were used to identify 
sample relatedness.
ompA genotypes were defined on the basis of homol-
ogy with reference strains of C. trachomatis. If >1 SNP was 
identified when sequences were compared to those of the 
closest hit reference strain, a number was used to denote 
the presence of the SNP(s) (e.g., Ia4) (15).
Strain Clustering and SNP Analyses
Strain clustering and SNP analyses were performed as 
described (11). Briefly, clusters of related and singleton STs 
as well as evolutionary patterns among the isolates and for 
the entire dataset were determined by using eBURST (http://
eburst.mlst.net). Neighbor-joining and minimum evolution 
methods in MEGA4 (http://www.megasoftware.net) were 
used to construct the trees along with multiple substitution 
models, including p-distance and Jukes-Cantor; all methods 
gave similar results. To test support for each node in the tree, 
we performed 1,000 bootstrap replicates.
All SNPs were identified for each ST by using the 
PROC FREQ tool in SAS software (SAS Institute, Cary, 
NC, USA). The probability of association of a SNP with 
an ST was determined by using a classification index (16). 
Variance across the dataset was determined using the Lev-
ene test (17). A p value <0.05 was considered significant.
Results
MLST Discrimination of C. trachomatis
The Table shows the distribution of MLST STs and 
ompA genotypes for each dyad with SNP location(s), if 
present, for each of the 7 MLST housekeeping genes. We 
noted that in some cases, the DNA extracted directly from 
the patient sample was sufficient for MLST, whereas in 
other cases, the cultured sample was required because the 
patient sample did not yield sufficient DNA for MLST. We 
found no differences in MLST results when we compared 
DNA directly extracted from the patient sample with DNA 
extracted from the culture of the same sample.
For each of the 28 dyads, both partners had the same 
MLST ST. A total of 9 STs were found in the 56 sam-
ples from the 28 dyads: ST15, ST19, ST23, ST34, ST39, 
ST45, ST46, ST47, and ST55. Twenty-one dyads harbored 
MLST STs that matched STs of samples obtained from 
geographically diverse areas currently included in the 
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MLST database, whereas 7 dyads harbored newly iden-
tified STs not present in the database (online Technical 
Appendix Table 2). Among these 7 dyads, 4 MLST STs 
were unique to Indianapolis: ST45 (dyad 22), ST46 (dyads 
23–26), ST47 (dyad 27), and ST55 (dyad 28); these results 
reflect the SNPs in various alleles (Table).
 
Table. Chlamydia trachomatis ompA genotypes, MLSTs, and SNPs for samples from heterosexual patient pairs (dyads) in 
Indianapolis, Indiana, USA, April 2000–October 2003* 
Dyad no. Sample nos. ompA genotype ST 
ompA genotype(s) associated with ST–closest hit genotype 
homology (SNPs)† 
1 J/112i J/UW36/Cx 15 J/UW36/Cx & K/UW36/Cx–K/42nl & K/49nl  
 J/113i    
2 K/186i K/UW36/Cx 15 J/UW36/Cx & K/UW36/Cx–K/42nl & K/49nl  
 K/187i    
3 H/114i H/UW4/Cx 19 D/UW3/Cx, G/UW57/Cx, H/UW4/Cx, I/UW12/Ur, J/UW36/Cx–
G/SotonG1   H/115i   
4 Ia/94i Ia/UW202 23 D/UW3/Cx, Ia/UW202–Ia/UW202  
 Ia/95i    
5 Ia/118i Ia/UW202 23 D/UW3/Cx, Ia/UW202–Ia/UW202  
 Ia/119i    
6 Ia4/177i Ia4 23 D/UW3/Cx, Ia/UW202, Ia4–Ia/UW202  
 Ia4/180i    
7 Ia/178i Ia/UW202 23 D/UW3/Cx, Ia/UW202–Ia/UW202  
 Ia/179i    
8 Ia/183i Ia/UW202 23 D/UW3/Cx, Ia/UW202–Ia/UW202  
 Ia/184i    
9 D2/96i D2 34 D2, D/UW3/Cx, E/Bour, F/ICCal3, Ja/UW92–F/ICCal3  
 D2/97i    
10 F/98i F/ICCal3 34 D2, D/UW3/Cx, E/Bour, F/ICCal3, Ja/UW92–F/ICCal3  
 F/99i    
11 F/181i F/ICCal3 34 D2, D/UW3/Cx, E/Bour, F/ICCal3, Ja/UW92–F/ICCal3  
 F/182i    
12 D2/189i D2 34 D2, D/UW3/Cx, E/Bour, F/ICCal3, Ja/UW92–F/ICCal3  
 D2/190i    
13 F/191i F/ICCal3 34 D2, D/UW3/Cx, E/Bour, F/ICCal3, Ja/UW92–F/ICCal3  
 F/192i    
14 E/88i E/Bour 39 E/Bour–E/Bour  
 F/89i    
15 E/102i E/Bour 39 E/Bour–E/Bour  
 E/103i    
16 E/106i E/Bour 39 E/Bour–E/Bour  
 E/107i    
17 E/116i E/Bour 39 E/Bour–E/Bour  
 E/117i    
18 E6/120i E/Bour 39 E/Bour–E/Bour  
 E6/121i    
19 E/108i E/Bour 39 E/Bour–E/Bour  
 E/109i    
20 E/110i E/Bour 39 E/Bour–E/Bour  
 E/111i    
21 E/171i E/Bour 39 E/Bour–E/Bour  
 E/172i    
22 D1/90i D1 45 D1–F/ICCal3 (glyA: 176, 264) 
 D1/91i    
23 E/92i E/Bour 46 E/Bour–Da/TW448 (leuS: 58, 96) 
 E/93i    
24 E/104i E/Bour 46 E/Bour–Da/TW448 (leuS: 58, 96) 
 E/105i    
25 E/173i E/Bour 46 E/Bour–Da/TW448 (leuS: 58, 96) 
 E/174i    
26 E/185i E/Bour 46 E/Bour–Da/TW448 (leuS: 58, 96) 
 E/188i    
27 E/100i E/Bour 47 E/Bour–E/Bour (hybG: 257, 289, 451; pykF: 317, 384) 
 E/101i    
28 F4/175i F4 55 F4–F/ICCal3 (leuS: 44) 
 F4/176i    
*Boldface indicates putative recombinant strains. MLST, multilocus sequence typing; SNP, single-nucleotide polymorphism; ST, sequence type. 
†ompA genotypes that are associated with each ST are listed; after the dash, the genotype that is the closest hit for the 7 MLST housekeeping genes is 
listed. In some cases, the closest hit is a reference strain with SNPs in a gene; the location of the SNP is listed based on the start position of the gene as 
designated by the genome sequence of D/UW3/Cx (GenBank accession no. AE001273.1). 
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Eleven ompA genotypes were represented in the study 
and, by study design, were identical within dyads. The 
ompA genotypes included E, F, H, Ia, J, and K sequences 
that were identical to those of reference strains and 5 vari-
ant ompA genotypes of D1, D2, E6, F4, and Ia4 that had 
SNPs compared with the reference strains.
By combining MLST ST and ompA genotype data, 
we identified 13 unique strains (9 by MLST and 4 by 
ompA genotype) among the samples from our study group. 
Among these 13 strains, 8 were unique to Indianapolis and 
were found in 12 dyads (dyads 1, 6, 9, 12, 18, 22, 23, 24, 
25, 26, 27, and 28) (Table; online Technical Appendix 
Table 2). Moreover, of the 13 strains identified among the 
dyad samples, 9 (69%) contained gene sequences that sug-
gested recombination within the genome, meaning that the 
ompA genotype was different from the ompA genotype that 
should be associated with the MLST ST if the genome were 
just 1 strain. For example, for strains from dyads 10 and 12, 
the ompA was D2, but the sequences of the 7 housekeeping 
genes (MLST ST34) matched the 7 housekeeping genes of 
strain F/ICCal3 from the MLST database. Putative recom-
binants (boldface in Table) represented a rate of 32% (9 of 
28 samples).
MLST STs and ompA genotypes for each sample in 
the MLST dataset are shown in online Technical Appendix 
Table 2. We found substantial variability of ompA geno-
types associated with MLST STs, as shown previously 
(11). For the STs for the 56 Indianapolis samples, ST15 
was associated with ompA genotypes J and K; ST34 was 
associated with ompA genotypes D2, E, and F; and ST19 
was associated with ompA genotypes D, G, H, I, and J. on-
line Technical Appendix Table 3 shows the characteristics 
of the alleles for each MLST locus based on the inclusion 
of the Indianapolis dataset in the MLST database.
Phylogeny of STs by Disease Phenotype  
and Evidence for Recombination
The association of disease phenotype with 3 clonal 
complexes (CCs) was identified by eBURST (Figure 1), 
similar to those we reported previously: C. trachomatis 
strains that cause trachoma A, B, Ba, and C (CC-A); non-
invasive STIs with low population prevalence (CC-B); and 
noninvasive, globally prevalent D/Da, E, and F STIs (CC-
C). The Indianapolis strains were confined to noninvasive 
STI CCs (B and C), as expected. The strains associated 
with 3 of the 4 unique STs in the Indianapolis samples are 
seen in CC-C (Figure 1).
The minimum-evolution tree also displayed 3 disease 
clusters (Figure 2); each of the Indianapolis strains is de-
noted next to the corresponding ST. Cluster I grouped non-
invasive, low-prevalence STIs (eBURST CC-B), including 
a subcluster of strains that cause trachoma (eBURST CC-
A). Cluster II grouped only invasive LGV strains. Cluster 
III grouped noninvasive, prevalent D/Da, E, and F STIs 
(eBURST CC-C). The tree constructed based on amino 
acid analysis showed similar clustering (data not shown).
The 9 putative Indianapolis recombinants were local-
ized on the MLST tree with strains of the same ompA geno-
type and were recombinants of strains within the same clus-
ter. Most recombinants were in cluster III. Four dyads with 
ST46 (unique to Indianapolis) had ompA genotype E and 
homology of the 7 housekeeping genes to reference strain 
Da/TW448 but with SNPs in leuS. D1/90i and D1/91i 
(ST45) and D2/96i, D2/97i, D2/189i, and D2/190i (ST34) 
were recombinants with homology to F/ICCal3 with SNPs 
in glyA and F/ICCal3, respectively. In cluster I, J/112i and 
J/113i shared the same ST as K/186i and K/187i and were 
recombinants with K/42nl and K/49nl. H/114i and H/115i 
were recombinants with G/SotonG1.
Discussion
We investigated a well-defined, epidemiologically 
linked partner cohort of persons with C. trachomatis infec-
tion in which members of each dyad shared strains with 
identical ompA genotype and found that MLST ST was 
identical as well. This study confirms the reproducibility 
of MLST and short-term (≈30 days) stability of MLST in 
the context of a sexual partnership in which transmission 
has likely occurred. Whereas the identification of 8 unique 
C. trachomatis strains in Indianapolis was not surprising, 
given that samples from this city had not previously been 
subjected to MLST, the rate of 32% (9/28 samples) for 
recombinants was striking. We only considered 28 dyads 
in our analyses of strain diversity because of the closely 
defined epidemiologic link within the partnerships and the 
fact that strains were identical within dyads.
Because MLST provides >3 times the genetic data of 
ompA, the additional discriminatory power of this typing 
method is not surprising. We found that 8 of the 28 India-
napolis dyads (dyads 1 and 22–28) contained ompA geno-
types that did not match our previous associations of ompA 
genotype with MLST STs in the MLST database (Table). 
For example, a J strain by ompA genotyping was associated 
with the MLST ST of a K strain (dyad 1); an ompA E strain 
was associated with the MLST ST of a Da strain (dyads 
23–26); an ompA D1 strain was associated with the MLST 
ST of an F strain with SNPs in glyA (dyad 22); an ompA 
E strain was associated with the MLST ST of an E strain 
with 3 SNPs in hybG and 2 in pykF (dyad 27); and an ompA 
strain F4 matched the MLST of an F strain with an SNP in 
leuS (dyad 28). 
ompA genotyping should not be considered a for-
mal part of an MLST scheme because it is under immune 
selection (18), and housekeeping genes provide a stable 
evolutionary marker for STs. However, ompA genotyp-
ing remains a useful tool because it has been the mainstay 
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of typing C. trachomatis for >20 years and is valuable 
for comparison with strains typed only by this method. 
Furthermore, ompA genotyping, but not MLST, was able 
to identify 2 dyads in which partners were infected with 
strains exhibiting mutations in ompA that had not previ-
ously been detected: E6 (dyad 18) and Ia4 (dyad 6) (Ta-
ble). This result indicates utility in continuing ompA ge-
notyping as a separate but adjunctive method with MLST 
for epidemiologic and transmission studies and for estab-
lishing strain concordance among members of less well-
defined partnerships.
We further identified 3 clonal complexes that corre-
lated with phenotypic disease, similar to previous findings 
(11). Most Indianapolis samples clustered with noninva-
sive D/Da, E, and F strains in CC-C (Figure 1), a result 
that is expected, given that these strains are the most preva-
lent worldwide (19–22). Whereas the Indianapolis samples 
were represented in 9 STs, 4 of these STs were distinct for 
this city, which suggests some clonal expansion of those 
unique strains in this area.
Genomic characteristics may also drive specific 
events, such as recombination, that may result in clonal 
expansion within a relatively small sexual network. Re-
combinants of the most prevalent urogenital ompA geno-
types E, F, and D have previously been reported (23,24). 
Several reports have also been published regarding recom-
binants between genotypes D, E, and F and ompA gen-
otype J (11,24,25); recombinants of LGV and D strains 
have also been documented (6,10,23), and previous MLST 
studies have shown evidence for recombination (7,10,11). 
In a previous study, we found 9 (17%) of 53 urogenital 
samples, excluding all ocular samples from patients with 
trachoma, were recombinant among a geographic distribu-
tion that included the western United States, Portugal, the 
Netherlands, and Ecuador (11). 
In this study, members of 9 (32%) of the 28 dyads 
were infected with strains that contained gene sequences 
suggesting recombination within the genome (Table); this 
was the case for 2 of 4 STs that were unique to Indianapolis 
(STs 45 and 46). The 9 putative recombinants were local-
ized on the MLST tree with strains of the same ompA gen-
otype and, not surprisingly, were recombinants of strains 
within the same cluster (Figure 1). Our sample size was 
small, but the high rate of recombination suggests emerg-
ing diversity within a tight sexual network. This hypothesis 
is supported by historic studies of ompA genotypes among 
patients attending inner city STD clinics; in one such exam-
ple, Ia genotypes that have much lower prevalence in other 
parts of the United States predominated among patients 
in Birmingham, Alabama, and were more prevalent than 
Figure 1. Population snapshot for Chlamydia trachomatis samples collected during April 2000–October 2003 from members of heterosexual 
partnerships (dyads) in Indianapolis, Indiana, USA, compared with reference strains. Data were compiled in eBURST (http://www.mlst.
net). Three distinct clonal complexes (CCs) are shown, along with numerous singletons of various sizes and 1 doublet. CC-A, strains 
causing trachoma; CC-B, noninvasive, nonprevalent urogenital strains; CC-C, noninvasive, globally prevalent urogenital strains. Samples 
from Indianapolis are highlighted in yellow (shown with sample identification number) and are restricted to clusters I and III. Each circle 
represents a sequence type (ST) at the point where linked STs within each CC are likely to have descended from the same recent 
ancestor. The area of the circle denotes the number of samples for that ST. The primary founder of the CC is at the hub; subgroup founders 
are represented as secondary hubs (e.g., C/35n).
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genotype D, which was the third most prevalent genotype 
for all other cities studied (26).
Our study has several strengths. Availability of the 
concordance study with carefully defined sexual partner-
ships, application of MLST to confirm the concordance of 
samples between dyads and to identify unique strains, and 
use of full-length ompA sequences enabled us to identify 
ompA variants and compare and combine the results of the 
2 strain typing methods. The weaknesses of our study in-
clude the relatively small numbers of sexual partners and 
that only concordant dyads with epidemiologically linked 
strains were studied, limiting our conclusions about the 
overall diversity of strains in Indianapolis, which are likely 
much larger than what we discovered here.
In summary, our findings validate the discriminatory 
power of MLST for partnership and transmission studies of 
C. trachomatis infections among at-risk populations locally 
and globally. Larger partner and population studies that use 
MLST and ompA genotyping will provide valuable data on 
transmission concordance or discordance that will inform 
interventions and public health policy to better control C. 
trachomatis transmission. Furthermore, applying these 
tools globally will expand our knowledge of C. trachomatis 
strain diversity and their emergence among populations at 
risk for chlamydial STIs.
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